GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events

New SARS-CoV-2 variants of concern (VOCs) and waning immunity illustrate that quick and easy-to-use agents are needed to prevent infection. To protect from viral transmission and subsequent inflammatory reactions, we applied GlyperA™, a novel antimicrobial formulation that can be used as mouth gargl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaderer, Viktoria, Dichtl, Stefanie, Posch, Wilfried, Abiatari, Ivane, Bonn, Günther K., Jakschitz, Thomas, Huber, Lukas A., Kurzchalia, Teymuras V., Wilflingseder, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032620/
https://www.ncbi.nlm.nih.gov/pubmed/36949547
http://dx.doi.org/10.1186/s12931-023-02397-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032620/
https://www.ncbi.nlm.nih.gov/pubmed/36949547
http://dx.doi.org/10.1186/s12931-023-02397-3

Ejemplares similares